April 1, 2022  -  Investment Round-upsNews

Femtech Investment Round-up: March 2022

At the beginning of each month, we look back and share which companies have announced new funding rounds. Below is February 2022’s round-up.

Investments

Berlin-based LEVY Health raises €2.5M for its CE-compliant Infertility Diagnostics Platform.

Australian Baymatob raises $3M for Oli, its AI-guided PPH monitoring device.

Alife raises $22M in Series A funding to modernize and personalize fertility care with AI.

Maternal health startup Noula Health raises $1.4M in pre-seed funding.

Zaya raises a $7.6M seed round to make European-inspired maternal care accessible in the U.S.

Wildflower Health raises $26M to support the national expansion of its value-based maternity care offerings.

Delfina raises $5.3M for its AI-powered pregnancy platform to address the maternal health crisis in the U.S. and beyond.

Bladder care startup Jude raises £2M in pre-seed funding to invest in R&D.

CancerIQ raises a $14M Series B for its cancer-focused precision health platform.

Vyld closes a pre-seed round (size undisclosed) to take its seaweed-made tampons into mass production.

Acquisition

Carlyle and PAI Partners agree to acquire women's health pharma company Theramex.

Ro acquires sperm analysis and storage company Dadi.

Private Equity firm Yellow Wood Partners launches a new sexual wellness platform after acquiring several brands from Clio.

Other

SteelSky Ventures raises $72M for its inaugural fund to invest in women's health.

Serena Ventures raises a $111M venture fund to invest in underrepresented founders.